1332760-73-2

Upstream product

• 450-91-9 4-fluoro-2-methoxyaniline 
• 53981-24-1 2-amino-5-fluorophenol 
• 1332760-72-1 4-{2-[1-(3-tert-butoxycarbonylamino-propylcarbamoyl)ethoxy]-4-fluoro-phenylamino}-5-methyl-thieno[2,3-d]pyrimidine-6-carboxylic acid 
• 1332634-79-3 4-(4-Fluoro-2-hydroxy-phenylamino)-5-methyl-thieno[2,3-d]pyrimidine-6-carboxylic acid methyl ester 
• 1332760-70-9 4-{2-[1-(3-tert-Butoxycarbonylamino-propylcarbamoyl)-ethoxy]-4-fluoro-phenylamino}-5-methyl-thieno[2,3-d]pyrimidine-6-carboxylic acid methyl ester 
• 1332759-62-2 4-[2-(1-tert-butoxycarbonyl-ethoxy)-4-fluoro-phenylamino]-5-methyl-thieno[2,3-d]pyrimidine-6-carboxylic acid methyl ester 
• 1332759-63-3 4-[2-(1-Carboxy-ethoxy)-4-fluoro-phenylamino]-5-methyl-thieno[2,3-d]pyrimidine-6-carboxylic acid methyl ester 
• 1332761-22-4 4-(4-fluoro-2-methoxy-phenylamino)-5-methyl-thieno[2,3-d]pyrimidine-6-carboxylic acid methyl ester 
• 832113-96-9 methyl 4-chloro-5-methylthieno[2,3-d]pyrimidine-6-carboxylate 

Relevant academic research and scientific papers

THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS

The present invention relates to novel thienopyhmidine compounds of general formula pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.

THIENOPYRIMIDINES CONTAINING A SUBSTITUTED ALKYL GROUP FOR PHARMACEUTICAL COMPOSITIONS

The present invention relates to novel thienopyrimidine compounds of general formula pharmaceutical compositions comprising these compounds and their therapeutic use for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.